PDB Short entry for 3L0T HEADER HYDROLASE/HYDROLASE INHIBITOR 10-DEC-09 3L0T TITLE CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN COMPND 3 17; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: RESIDUES 215-476; COMPND 6 SYNONYM: ADAM 17, TNF-ALPHA-CONVERTING ENZYME, TNF-ALPHA CONVERTASE, COMPND 7 SNAKE VENOM-LIKE PROTEASE; COMPND 8 EC: 3.4.24.86; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADAM17, CSVP, TACE; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS METAL-BINDING, METALLOPROTEASE, NOTCH SIGNALING PATHWAY, PROTEASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 4 06-SEP-23 3L0T 1 REMARK REVDAT 3 13-OCT-21 3L0T 1 SEQADV LINK REVDAT 2 05-MAY-10 3L0T 1 JRNL REVDAT 1 02-MAR-10 3L0T 0 JRNL AUTH W.YU,Z.GUO,P.ORTH,V.MADISON,L.CHEN,C.DAI,R.J.FELTZ, JRNL AUTH 2 V.M.GIRIJAVALLABHAN,S.H.KIM,J.A.KOZLOWSKI,B.J.LAVEY,D.LI, JRNL AUTH 3 D.LUNDELL,X.NIU,J.J.PIWINSKI,J.POPOVICI-MULLER,R.RIZVI, JRNL AUTH 4 K.E.ROSNER,B.B.SHANKAR,N.Y.SHIH,M.A.SIDDIQUI,J.SUN,L.TONG, JRNL AUTH 5 S.UMLAND,M.K.WONG,D.Y.YANG,G.ZHOU JRNL TITL DISCOVERY AND SAR OF HYDANTOIN TACE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 1877 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20172725 JRNL DOI 10.1016/J.BMCL.2010.01.148 REMARK 2 REMARK 2 RESOLUTION. 1.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 44155 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.890 REMARK 3 FREE R VALUE TEST SET COUNT : 835 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3903 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 255 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.01940 REMARK 3 B22 (A**2) : 4.67790 REMARK 3 B33 (A**2) : 0.34150 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.262 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3L0T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-DEC-09. REMARK 100 THE DEPOSITION ID IS D_1000056689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : USE OF THE IMCA-CAT BEAMLINE 17 REMARK 200 -ID AT THE ADVANCED PHOTON REMARK 200 SOURCE WAS SUPPORTED BY THE REMARK 200 COMPANIES OF THE INDUSTRIAL REMARK 200 MACROMOLECULAR CRYSTALLOGRAPHY REMARK 200 ASSOCIATION THROUGH A CONTRACT REMARK 200 WITH THE CENTER FOR ADVANCED REMARK 200 RADIATION SOURCES AT THE REMARK 200 UNIVERSITY OF CHICAGO. USE OF REMARK 200 THE ADVANCED PHOTON SOURCE WAS REMARK 200 SUPPORTED BY THE U. S. REMARK 200 DEPARTMENT OF ENERGY, OFFICE OF REMARK 200 SCIENCE, OFFICE OF BASIC ENERGY REMARK 200 SCIENCES, UNDER CONTRACT NO. W- REMARK 200 31-109-ENG-38 REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44264 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.920 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 10.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1BKC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 6K, 10% 2-PROPANOL, 100 MM REMARK 280 SODIUM CITRATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.09900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.36200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.75600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.36200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.09900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.75600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 215 REMARK 465 ALA A 216 REMARK 465 ASP A 217 REMARK 465 ARG A 357 REMARK 465 ALA A 358 REMARK 465 ASN A 359 REMARK 465 ASN A 475 REMARK 465 LYS A 476 REMARK 465 GLY A 477 REMARK 465 SER A 478 REMARK 465 HIS A 479 REMARK 465 HIS A 480 REMARK 465 HIS A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 ARG B 215 REMARK 465 ALA B 216 REMARK 465 ASP B 217 REMARK 465 PRO B 218 REMARK 465 ASP B 219 REMARK 465 SER B 474 REMARK 465 ASN B 475 REMARK 465 LYS B 476 REMARK 465 GLY B 477 REMARK 465 SER B 478 REMARK 465 HIS B 479 REMARK 465 HIS B 480 REMARK 465 HIS B 481 REMARK 465 HIS B 482 REMARK 465 HIS B 483 REMARK 465 HIS B 484 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 241 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 302 CG CD CE NZ REMARK 470 GLU A 427 CG CD OE1 OE2 REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 VAL A 440 CG1 CG2 REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 LYS A 448 CE NZ REMARK 470 LYS A 460 CG CD CE NZ REMARK 470 MET B 221 CG SD CE REMARK 470 LYS B 222 CG CD CE NZ REMARK 470 LYS B 226 CE NZ REMARK 470 ARG B 237 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 241 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 283 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 286 CE NZ REMARK 470 SER B 287 OG REMARK 470 GLU B 290 CG CD OE1 OE2 REMARK 470 LYS B 302 CG CD CE NZ REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 LYS B 309 CG CD CE NZ REMARK 470 LYS B 315 CE NZ REMARK 470 LYS B 331 NZ REMARK 470 LYS B 367 CE NZ REMARK 470 LYS B 392 CG CD CE NZ REMARK 470 GLU B 422 CG CD OE1 OE2 REMARK 470 GLU B 427 CG CD OE1 OE2 REMARK 470 ASP B 428 CG OD1 OD2 REMARK 470 GLU B 445 CG CD OE1 OE2 REMARK 470 LYS B 448 CE NZ REMARK 470 LYS B 460 CG CD CE NZ REMARK 470 GLU B 463 CG CD OE1 OE2 REMARK 470 LYS B 465 CG CD CE NZ REMARK 470 GLN B 467 CG CD OE1 NE2 REMARK 470 GLU B 472 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 270 -127.66 -137.50 REMARK 500 CYS A 365 125.50 76.88 REMARK 500 ASN A 381 51.38 -94.20 REMARK 500 VAL A 440 -86.95 -46.91 REMARK 500 SER A 441 -34.82 139.52 REMARK 500 ALA B 270 -108.02 -123.43 REMARK 500 CYS B 365 122.49 78.48 REMARK 500 ASN B 381 51.09 -90.68 REMARK 500 CYS B 469 -6.38 -142.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 405 NE2 REMARK 620 2 HIS A 409 NE2 99.9 REMARK 620 3 HIS A 415 NE2 100.8 99.0 REMARK 620 4 INN A 502 O 109.0 146.0 93.0 REMARK 620 5 INN A 502 O4 96.9 89.0 159.0 70.4 REMARK 620 6 HOH A 716 O 172.2 79.8 87.0 69.2 75.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 405 NE2 REMARK 620 2 HIS B 409 NE2 95.8 REMARK 620 3 HIS B 415 NE2 105.2 98.8 REMARK 620 4 Z94 B 502 N7 108.7 139.3 105.0 REMARK 620 5 Z94 B 502 O12 89.2 91.1 161.5 58.5 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: N-{(2R)-2-[2-(HYDROXYAMINO)-2-OXOETHYL]-4- REMARK 630 METHYLPENTANOYL}-3-METHYL-L-VALYL-N-(2-AMINOETHYL)-L-ALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 INN A 502 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 2HM TBG ALA EDN REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE INN A 485 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z94 B 485 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA B 8 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BKC RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) REMARK 900 RELATED ID: 3KMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE-BASED REMARK 900 INHIBITOR REMARK 900 RELATED ID: 3KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL- REMARK 900 PYRROLIDINYL-TARTRATE INHIBITOR REMARK 900 RELATED ID: 3L0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST REMARK 900 HYDANTOIN INHIBITOR OCCUPYING THE S1 POCKET REMARK 900 RELATED ID: 3LE9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH INDAZOLINONE- REMARK 900 PHENYL-HYDANTOIN INHIBITOR REMARK 900 RELATED ID: 3LEA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH REMARK 900 ISOINDOLINONE-BIPHENYL-HYDANTOIN INHIBITOR DBREF 3L0T A 215 476 UNP P78536 ADA17_HUMAN 215 476 DBREF 3L0T B 215 476 UNP P78536 ADA17_HUMAN 215 476 SEQADV 3L0T ALA A 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 3L0T GLY A 353 UNP P78536 VAL 353 ENGINEERED MUTATION SEQADV 3L0T GLN A 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 3L0T GLY A 477 UNP P78536 EXPRESSION TAG SEQADV 3L0T SER A 478 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS A 479 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS A 480 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS A 481 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS A 482 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS A 483 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS A 484 UNP P78536 EXPRESSION TAG SEQADV 3L0T ALA B 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 3L0T GLY B 353 UNP P78536 VAL 353 ENGINEERED MUTATION SEQADV 3L0T GLN B 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 3L0T GLY B 477 UNP P78536 EXPRESSION TAG SEQADV 3L0T SER B 478 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS B 479 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS B 480 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS B 481 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS B 482 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS B 483 UNP P78536 EXPRESSION TAG SEQADV 3L0T HIS B 484 UNP P78536 EXPRESSION TAG SEQRES 1 A 270 ARG ALA ASP PRO ASP PRO MET LYS ASN THR CYS LYS LEU SEQRES 2 A 270 LEU VAL VAL ALA ASP HIS ARG PHE TYR ARG TYR MET GLY SEQRES 3 A 270 ARG GLY GLU GLU SER THR THR THR ASN TYR LEU ILE GLU SEQRES 4 A 270 LEU ILE ASP ARG VAL ASP ASP ILE TYR ARG ASN THR ALA SEQRES 5 A 270 TRP ASP ASN ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE SEQRES 6 A 270 GLU GLN ILE ARG ILE LEU LYS SER PRO GLN GLU VAL LYS SEQRES 7 A 270 PRO GLY GLU LYS HIS TYR ASN MET ALA LYS SER TYR PRO SEQRES 8 A 270 ASN GLU GLU LYS ASP ALA TRP ASP VAL LYS MET LEU LEU SEQRES 9 A 270 GLU GLN PHE SER PHE ASP ILE ALA GLU GLU ALA SER LYS SEQRES 10 A 270 VAL CYS LEU ALA HIS LEU PHE THR TYR GLN ASP PHE ASP SEQRES 11 A 270 MET GLY THR LEU GLY LEU ALA TYR GLY GLY SER PRO ARG SEQRES 12 A 270 ALA ASN SER HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SEQRES 13 A 270 SER PRO VAL GLY LYS LYS ASN ILE TYR LEU ASN SER GLY SEQRES 14 A 270 LEU THR SER THR LYS ASN TYR GLY LYS THR ILE LEU THR SEQRES 15 A 270 LYS GLU ALA ASP LEU VAL THR THR HIS GLU LEU GLY HIS SEQRES 16 A 270 ASN PHE GLY ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU SEQRES 17 A 270 CYS ALA PRO ASN GLU ASP GLN GLY GLY LYS TYR VAL MET SEQRES 18 A 270 TYR PRO ILE ALA VAL SER GLY ASP HIS GLU ASN ASN LYS SEQRES 19 A 270 MET PHE SER GLN CYS SER LYS GLN SER ILE TYR LYS THR SEQRES 20 A 270 ILE GLU SER LYS ALA GLN GLU CYS PHE GLN GLU ARG SER SEQRES 21 A 270 ASN LYS GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 B 270 ARG ALA ASP PRO ASP PRO MET LYS ASN THR CYS LYS LEU SEQRES 2 B 270 LEU VAL VAL ALA ASP HIS ARG PHE TYR ARG TYR MET GLY SEQRES 3 B 270 ARG GLY GLU GLU SER THR THR THR ASN TYR LEU ILE GLU SEQRES 4 B 270 LEU ILE ASP ARG VAL ASP ASP ILE TYR ARG ASN THR ALA SEQRES 5 B 270 TRP ASP ASN ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE SEQRES 6 B 270 GLU GLN ILE ARG ILE LEU LYS SER PRO GLN GLU VAL LYS SEQRES 7 B 270 PRO GLY GLU LYS HIS TYR ASN MET ALA LYS SER TYR PRO SEQRES 8 B 270 ASN GLU GLU LYS ASP ALA TRP ASP VAL LYS MET LEU LEU SEQRES 9 B 270 GLU GLN PHE SER PHE ASP ILE ALA GLU GLU ALA SER LYS SEQRES 10 B 270 VAL CYS LEU ALA HIS LEU PHE THR TYR GLN ASP PHE ASP SEQRES 11 B 270 MET GLY THR LEU GLY LEU ALA TYR GLY GLY SER PRO ARG SEQRES 12 B 270 ALA ASN SER HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SEQRES 13 B 270 SER PRO VAL GLY LYS LYS ASN ILE TYR LEU ASN SER GLY SEQRES 14 B 270 LEU THR SER THR LYS ASN TYR GLY LYS THR ILE LEU THR SEQRES 15 B 270 LYS GLU ALA ASP LEU VAL THR THR HIS GLU LEU GLY HIS SEQRES 16 B 270 ASN PHE GLY ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU SEQRES 17 B 270 CYS ALA PRO ASN GLU ASP GLN GLY GLY LYS TYR VAL MET SEQRES 18 B 270 TYR PRO ILE ALA VAL SER GLY ASP HIS GLU ASN ASN LYS SEQRES 19 B 270 MET PHE SER GLN CYS SER LYS GLN SER ILE TYR LYS THR SEQRES 20 B 270 ILE GLU SER LYS ALA GLN GLU CYS PHE GLN GLU ARG SER SEQRES 21 B 270 ASN LYS GLY SER HIS HIS HIS HIS HIS HIS HET ZN A 501 1 HET INN A 502 29 HET IPA A 503 4 HET ZN B 501 1 HET Z94 B 502 34 HET IPA B 503 4 HETNAM ZN ZINC ION HETNAM INN N-{(2R)-2-[2-(HYDROXYAMINO)-2-OXOETHYL]-4- HETNAM 2 INN METHYLPENTANOYL}-3-METHYL-L-VALYL-N-(2-AMINOETHYL)-L- HETNAM 3 INN ALANINAMIDE HETNAM IPA ISOPROPYL ALCOHOL HETNAM Z94 N-{4-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4-YL]PHENYL}ACETAMIDE HETSYN IPA 2-PROPANOL HETSYN Z94 2-(5-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC HETSYN 2 Z94 ACID FORMUL 3 ZN 2(ZN 2+) FORMUL 4 INN C19 H37 N5 O5 FORMUL 5 IPA 2(C3 H8 O) FORMUL 7 Z94 C11 H11 N3 O3 FORMUL 9 HOH *255(H2 O) HELIX 1 1 ASP A 232 MET A 239 1 8 HELIX 2 2 GLU A 243 ASN A 264 1 22 HELIX 3 3 ASP A 313 ILE A 325 1 13 HELIX 4 4 ILE A 325 SER A 330 1 6 HELIX 5 5 PHE A 343 THR A 347 5 5 HELIX 6 6 LEU A 395 PHE A 411 1 17 HELIX 7 7 ASN A 426 GLY A 430 5 5 HELIX 8 8 SER A 451 PHE A 470 1 20 HELIX 9 9 ASP B 232 MET B 239 1 8 HELIX 10 10 GLU B 243 ASN B 264 1 22 HELIX 11 11 ASP B 313 ILE B 325 1 13 HELIX 12 12 ILE B 325 SER B 330 1 6 HELIX 13 13 PHE B 343 THR B 347 5 5 HELIX 14 14 LEU B 395 PHE B 411 1 17 HELIX 15 15 ASN B 426 GLY B 430 5 5 HELIX 16 16 HIS B 444 MET B 449 5 6 HELIX 17 17 SER B 451 PHE B 470 1 20 SHEET 1 A 5 GLY A 276 ILE A 284 0 SHEET 2 A 5 THR A 224 ALA A 231 1 N VAL A 229 O GLN A 281 SHEET 3 A 5 LEU A 334 THR A 339 1 O PHE A 338 N VAL A 230 SHEET 4 A 5 SER A 382 SER A 386 1 O THR A 385 N THR A 339 SHEET 5 A 5 GLY A 349 ALA A 351 -1 N LEU A 350 O LEU A 384 SHEET 1 B 2 ALA A 368 SER A 371 0 SHEET 2 B 2 LYS A 376 TYR A 379 -1 O LYS A 376 N SER A 371 SHEET 1 C 2 LYS A 388 ASN A 389 0 SHEET 2 C 2 LYS A 392 THR A 393 -1 O LYS A 392 N ASN A 389 SHEET 1 D 5 GLY B 276 ILE B 284 0 SHEET 2 D 5 THR B 224 ALA B 231 1 N LEU B 227 O GLU B 280 SHEET 3 D 5 LEU B 334 THR B 339 1 O PHE B 338 N VAL B 230 SHEET 4 D 5 SER B 382 SER B 386 1 O THR B 385 N LEU B 337 SHEET 5 D 5 GLY B 349 ALA B 351 -1 N LEU B 350 O LEU B 384 SHEET 1 E 2 ALA B 368 SER B 371 0 SHEET 2 E 2 LYS B 376 TYR B 379 -1 O ILE B 378 N TYR B 369 SHEET 1 F 2 LYS B 388 ASN B 389 0 SHEET 2 F 2 LYS B 392 THR B 393 -1 O LYS B 392 N ASN B 389 SSBOND 1 CYS A 225 CYS A 333 1555 1555 2.05 SSBOND 2 CYS A 365 CYS A 469 1555 1555 2.02 SSBOND 3 CYS A 423 CYS A 453 1555 1555 2.02 SSBOND 4 CYS B 225 CYS B 333 1555 1555 2.05 SSBOND 5 CYS B 365 CYS B 469 1555 1555 2.03 SSBOND 6 CYS B 423 CYS B 453 1555 1555 2.04 LINK NE2 HIS A 405 ZN ZN A 501 1555 1555 2.03 LINK NE2 HIS A 409 ZN ZN A 501 1555 1555 2.12 LINK NE2 HIS A 415 ZN ZN A 501 1555 1555 2.04 LINK ZN ZN A 501 O INN A 502 1555 1555 2.15 LINK ZN ZN A 501 O4 INN A 502 1555 1555 2.41 LINK ZN ZN A 501 O HOH A 716 1555 1555 2.42 LINK NE2 HIS B 405 ZN ZN B 501 1555 1555 2.11 LINK NE2 HIS B 409 ZN ZN B 501 1555 1555 2.17 LINK NE2 HIS B 415 ZN ZN B 501 1555 1555 1.99 LINK ZN ZN B 501 N7 AZ94 B 502 1555 1555 1.92 LINK ZN ZN B 501 O12AZ94 B 502 1555 1555 2.67 CISPEP 1 TYR A 304 PRO A 305 0 3.79 CISPEP 2 TYR B 304 PRO B 305 0 4.29 CISPEP 3 SER B 355 PRO B 356 0 1.81 SITE 1 AC1 3 HIS A 405 HIS A 409 HIS A 415 SITE 1 AC2 18 GLU A 327 SER A 330 LYS A 331 MET A 345 SITE 2 AC2 18 GLY A 346 THR A 347 LEU A 348 GLY A 349 SITE 3 AC2 18 ASN A 389 TYR A 390 VAL A 402 HIS A 405 SITE 4 AC2 18 GLU A 406 HIS A 409 HIS A 415 PRO A 437 SITE 5 AC2 18 ILE A 438 ALA A 439 SITE 1 AC3 3 SER A 287 GLN A 289 ASN A 299 SITE 1 AC4 3 HIS B 405 HIS B 409 HIS B 415 SITE 1 AC5 12 THR B 347 LEU B 348 GLY B 349 LEU B 350 SITE 2 AC5 12 LEU B 401 VAL B 402 HIS B 405 GLU B 406 SITE 3 AC5 12 HIS B 409 HIS B 415 PRO B 437 ALA B 439 SITE 1 AC6 3 GLY B 346 ILE B 438 ALA B 439 CRYST1 74.198 75.512 102.724 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013477 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013243 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009735 0.00000